The Impact of 5-HT(3)RA Use on Cost and Utilization in Patients with Chemotherapy-Induced Nausea and Vomiting: Systematic Review of the Literature

BACKGROUND: Individual studies have assessed the impact of standard prophylactic therapy with 5-hydroxytryptamine receptor antagonists (5-HT(3)RAs) for chemotherapy-induced nausea and vomiting (CINV) on cost and utilization, but no synthesis of the findings exists. OBJECTIVE: To systematically revie...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Broder, Michael S., Faria, Claudio, Powers, Annette, Sunderji, Jehangeer, Cherepanov, Dasha
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Engage Healthcare Communications, LLC 2014
Gaiak:
Business
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4070626/
https://ncbi.nlm.nih.gov/pubmed/24991400
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak